This could be interesting. I am sure there are numerous companies racing to see if they can get an oral version of a Covid vaccine out into the market and especially booster tablets.
Oramed focuses on making oral delivery solutions for drugs typically delivered via injection. Its current focuses are an oral insulin capsule to be used for the treatment of individuals with diabetes, and the development of an oral COVID-19 vaccine for use both as a standalone vaccine and as a booster for people who have been previously vaccinated for COVID-19
The stock has run hard, up over 60% for this period. It had a deep 40% pull back and seems to be recovering nicely.
One to watch.
Comment
⋅
Nice 15% pullback into a value area as expected after a 50% run, so Ill be watching closely for an entry when it heads back up again. Probably tomorrow.
Comment
⋅
Price is a bit all over the place at the moment impacted by the wider market, but I do like the idea of this stock in terms of an oral covid vaccine. Will keep watching.